MAGNETOM Free.Max; MAGNETOM Free.Star
Siemens Medical Solutions USA, Inc. • Radiology • 11/09/2023
Device Purpose
The MAGNETOM Free.Max and MAGNETOM Free.Star systems, now featuring syngo MR XA60A software, are advanced magnetic resonance diagnostic devices designed for detailed anatomical and functional cross-sectional imaging, with the Free.Max model newly indicated for MR-guided interventional procedures. These capabilities are realized through updated hardware components like the Contour Knee coil and Respiratory Sensor, and significant software enhancements including the AI-based 'Deep Resolve Boost' for improved image quality and specialized applications such as 'myExam RT Assist' for radiotherapy support.
Summary
The MAGNETOM Free.Max and MAGNETOM Free.Star, operating with the new syngo MR XA60A software, are magnetic resonance diagnostic devices (MRDD) designed to produce detailed cross-sectional images (transverse, sagittal, coronal, oblique) of the head, body, or extremities, aiding physicians in diagnosis. These images can display internal structures and functions, and derived physical parameters can also be produced, with contrast agents used as needed. A key update for the MAGNETOM Free.Max is its extended indication for use in MR imaging during interventional procedures, utilizing MR-compatible devices like biopsy needles, a capability enabled by the new software. The MAGNETOM Free.Star maintains its established indications for use, producing images that assist in diagnosis when interpreted by a trained physician. These systems introduce several hardware and software enhancements compared to their predecessors using syngo MR XA50A software. New hardware includes the Contour Knee coil and a Respiratory Sensor, while the myExam 3D Camera, Host computer, and MaRS (Magnetom Remote Service) have been modified. Software innovations are extensive, featuring new applications such as Injector coupling, Respiratory Sensor Support, myExam Autopilot Hip, Complex Averaging, and the AI-driven 'Deep Resolve Boost' for image enhancement, which was trained on over 26,000 2D slices from 1.5T and 3T MRI scanners. For the MAGNETOM Free.Max specifically, new software includes myExam RT Assist, HASTE_Interactive, BEAT_Interactive, and Needle Intervention AddIn. Modified software features common to both systems include Deep Resolve Sharp, Deep Resolve Gain, and SMS Averaging. Non-clinical performance testing, including sample clinical images and software verification, demonstrated that these new and modified features perform as intended.
AI Regulatory Concerns
Powered by
Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.
Keywords
Device Metadata
Relevant Clinical Questions
- Q1. How does the 'Deep Resolve Boost' AI feature specifically improve image quality (e.g., SNR, resolution, artifact reduction) compared to previous versions or standard reconstruction, and what are its computational overheads?; What is the clinical impact and workflow integration of 'myExam RT Assist' for the MAGNETOM Free.Max, particularly concerning radiotherapy planning or guidance?; For the extended indication of interventional procedures with MAGNETOM Free.Max, what specific MR-compatible devices beyond biopsy needles have been validated, and what are the performance characteristics (e.g., image distortion, heating) when these are used?; Could you elaborate on the specific modifications to 'Deep Resolve Sharp' and 'Deep Resolve Gain' and how these changes enhance diagnostic capabilities or image interpretation?; What are the specific advantages or user benefits of the new 'Contour Knee coil' and 'Respiratory Sensor' in routine clinical practice, and how do they compare to previously available or third-party solutions?
Risk Classification
ESL AnalysisFDA Class II via 510(k) pathway; IEC 62304 Class C (software safety classification); Authorized before §524B enforcement
Learn how Parasoft automates IEC 62304 compliance testing →Cybersecurity Evidence
Powered by SBOMator™Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.
Supply Chain BOM Evidence
Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.
Analysis:
• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.
• Evidence of SaaSBOM, HBOM detected in AI-generated device summary.
• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.
• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.
• Not detected in AI-generated device summary: SBOM, ML-BOM, CBOM, VDR/VEX, OBOM. These may be present in the full FDA submission.
Preparing a similar submission?
ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.
Assess Your Readiness →Or contact ESL directly